Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TBPH
#2568
Theravance Biopharma, Inc.
16.640
0
USD
+0.24%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.24%
Monthly Change
+19.37%
6 month change
+15.96%
Year Change
+15.96%
Previous Close
16.600
0
Open
16.640
0
Bid
Ask
Low
16.640
0
High
16.640
0
Volume
77
Markets
US Stock Market
Healthcare
TBPH
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
49.47 M
50 M
50.36 M
50.67 M
51.49 M
—
Valuation ratios
Enterprise value
427.72 M
335.9 M
273.56 M
565.04 M
795.63 M
1.97 B
Price to earnings ratio
-8.18
-7.57
45.96
25.61
9.08
73.09
Price to sales ratio
7.14
6.71
7.1
9.15
8.97
31.93
Price to cash flow ratio
-39.85
13.72
2.28
3.03
4.04
23.06
Price to book ratio
2.62
0.61
0.73
0.92
3.25
5.5
Enterprise value to EBITDA ratio
-9.8
-6.93
-7.7
-18.13
-1 671.48
-1 704.24
Profitability ratios
Return on assets %
-0.04
-0.04
0.13
0.01
0.13
0.22
Return on equity %
-0.09
-0.08
0.24
0.02
0.21
0.38
Return on invested capital %
-25.43
-24.24
-5.71
41.13
58.52
69.7
Gross margin %
100
100
100
100
100
400
Operating margin %
-49.06
-93.8
-10.4
-32.29
43.61
-92.89
EBITDA margin %
-46.81
-91.12
-8.84
-30.27
44.48
-85.75
Net margin %
-82.79
-88.24
209.33
18.08
132.98
272.15
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.02
4.77
6.7
9.48
10.93
31.88
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.05
0.04
0.07
0.05
0.1
0.26
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.02
0.87
4.1
-0.13
-0.12
4.72
EBIT per share
-0.19
-0.29
-0.05
-0.12
0.39
-0.08
EBITDA per share
-0.18
-0.28
-0.05
-0.12
0.4
-0.05
Total debt per share
—
—
—
—
—
—
Cash per share
1.81
2.63
6.68
6.35
6.12
21.79
Net current asset value per share
3.3
3.02
7.22
6.83
8.12
25.2
Tangible book value per share
3.59
3.34
4.43
4.48
5.76
18.02
Working capital per share
2.64
2.39
6.14
6.11
7.38
22.03
Book value per share
3.59
3.34
4.43
4.48
5.76
18.02
News
Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock
Theravance's Q4 Earnings and Revenues Miss Estimates
Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)
Down 30.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)
Oppenheimer downgrades Theravance Biopharma stock rating on Phase 3 miss
TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
B.Riley cuts Theravance Biopharma stock rating on trial failure
Micron and MongoDB among market cap stock movers on Tuesday
BTIG cuts Theravance Biopharma stock price target on trial miss
The Excruciating Failure That Could Cause Theravance, Down 27%, To Sell Itself